GURU.Markets stock price, segment price, and overall market index valuation
The company's share price ReWalk Robotics Ltd.
ReWalk Robotics is a pioneer in the production of exoskeletons for people with spinal cord injuries. Its stock price reflects a long struggle to commercialize this revolutionary technology, which has been hampered by high costs and the difficulty of obtaining insurance coverage.
Share prices of companies in the market segment - Specialized medical equipment
ReWalk Robotics is a pioneer in rehabilitation robotics, producing exoskeletons that help people with spinal cord injuries walk again. We've classified the company as a "Specialized Medical Equipment" company. The chart below shows how the market views the wearable robotics sector.
Broad Market Index - GURU.Markets
ReWalk Robotics develops and manufactures exoskeletons for rehabilitation and mobility for people with lower limb paralysis. Its futuristic technology makes it a key component of the GURU.Markets index. The chart below represents the entire market. Find out how ReWalk compares to it.
Change in the price of a company, segment, and market as a whole per day
LFWD - Daily change in the company's share price ReWalk Robotics Ltd.
The daily fluctuations of Lifeward Ltd. (formerly ReWalk Robotics) shares reflect the volatility of the medical equipment sector. This metric is a measure of the sensitivity to demand for its exoskeletons for the rehabilitation of patients with spinal cord injuries.
Daily change in the price of a set of shares in a market segment - Specialized medical equipment
ReWalk Robotics creates exoskeletons that help people with limited mobility walk again. This is a cutting-edge sector of medical technology, where breakthroughs can spark rapid growth. The chart below shows the average volatility in the medical equipment niche, allowing you to compare LFWD dynamics with overall trends.
Daily change in the price of a broad market stock, index - GURU.Markets
ReWalk Robotics is a pioneer in the development of exoskeletons that help paralyzed people walk again. This futuristic company's stock reflects advances in robotics and rehabilitation. Its volatility is part of the dynamic of the innovation sector.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization ReWalk Robotics Ltd.
ReWalk Robotics Ltd.'s year-over-year performance is a story of the commercialization of its rehabilitation exoskeletons. Its market capitalization growth over the past 12 months reflects not only sales of its wearable walking devices but also its success in acquiring other companies, such as AlterG (anti-gravity treadmills), which diversifies its business.
Annual dynamics of market capitalization of the market segment - Specialized medical equipment
ReWalk Robotics is a pioneer in the development of exoskeletons for people with spinal cord injuries. Its stock price is extremely volatile, reflecting investors' faith in its breakthrough potential and ability to commercialize its futuristic technology, rather than its current financial performance.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
ReWalk Robotics, a pioneer in rehabilitation exoskeletons, is changing the lives of people with limited mobility. Its annual market capitalization dynamics reflect how quickly innovative medical technologies are entering clinical practice. The company's success depends on securing insurance coverage and expanding access to its devices.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization ReWalk Robotics Ltd.
ReWalk Robotics produces rehabilitation exoskeletons. Its monthly growth reflects progress in commercializing its products. Key drivers include sales growth and insurance approvals.
Monthly dynamics of market capitalization of the market segment - Specialized medical equipment
ReWalk Robotics Ltd. is a leading medical device company that creates exoskeletons that enable people with spinal cord injuries to walk again. The dynamics of its sector, shown in the graph, reflect innovation in medicine. Against this backdrop, one can appreciate how its revolutionary technologies are changing patients' lives and rehabilitation standards.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
ReWalk Robotics creates exoskeletons for the rehabilitation of people with spinal injuries. The company's stock is a bet on the future of robotics in medicine. Its performance depends on news of regulatory approvals and contracts with clinics. The chart will show movements reflecting investor confidence in this breakthrough technology.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization ReWalk Robotics Ltd.
ReWalk Robotics, a pioneer in the development of exoskeletons for people with paralysis, is at the forefront of medical technology. The company's weekly stock price reflects news about insurance company coverage decisions, technological advancements, and patient success stories, all of which inspire investors.
Weekly dynamics of market capitalization of the market segment - Specialized medical equipment
ReWalk Robotics creates exoskeletons for people with limited mobility. The company's success depends on technological breakthroughs and the adoption of its products in medical practice. A comparison with the sector will show whether investors are responding to the specifics of its business or to general trends in the medical equipment industry.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
ReWalk Robotics produces exoskeletons. This is a breakthrough technology, and its shares are highly sensitive to news about implementation and regulatory approvals. The chart will show how much its performance is detached from the broader market and driven by investor confidence in its unique product.
Market capitalization of the company, segment and market as a whole
LFWD - Market capitalization of the company ReWalk Robotics Ltd.
ReWalk Robotics' market capitalization chart is a financial reflection of the long journey from revolutionary idea to commercial reality. Its modest scale reflects how the market views the challenges of obtaining insurance coverage for its exoskeletons. Any growth on this chart reflects positive changes in reimbursement policies that could transform the lives of people with paralysis.
LFWD - Share of the company's market capitalization ReWalk Robotics Ltd. within the market segment - Specialized medical equipment
ReWalk Robotics is a pioneer in exoskeletons for people with spinal cord injuries. The company's market share in the medical device sector is small, but it is a leader in its revolutionary niche. Its market capitalization reflects both its commercial success and the potential of its technology to transform the lives of paralyzed people.
Market capitalization of the market segment - Specialized medical equipment
This graph shows the total value of the entire specialized medical equipment market. For ReWalk Robotics, a pioneer in rehabilitation exoskeletons, this line is a map of the future. The graph's growth reflects how robotic technologies are penetrating medicine, promising to restore mobility to people with spinal cord injuries.
Market capitalization of all companies included in a broad market index - GURU.Markets
ReWalk Robotics creates exoskeletons that enable paraplegics to walk again. Its market capitalization is the market valuation of a technology that restores hope and mobility. Globally, this represents a tiny but invaluable fraction of the dream of overcoming disability.
Book value capitalization of the company, segment and market as a whole
LFWD - Book value capitalization of the company ReWalk Robotics Ltd.
ReWalk Robotics is a pioneer in creating exoskeletons for people with paralysis. Its book value is derived from its technological and production assets: R&D centers, robotics patents, and inventory of finished systems. This is the material foundation for getting people back on their feet. How has this changed? The chart below shows.
LFWD - Share of the company's book capitalization ReWalk Robotics Ltd. within the market segment - Specialized medical equipment
ReWalk Robotics Ltd. is a pioneer in exoskeleton development. Its technology, which restores mobility to people, is developed in-house: assembly lines and R&D centers in Israel and the United States. The chart shows the company's share of the physical infrastructure required to produce advanced rehabilitation robotics.
Market segment balance sheet capitalization - Specialized medical equipment
ReWalk Robotics produces exoskeletons. The medical equipment sector, as the chart shows, is capital-intensive. ReWalk is a classic player. Its business consists of R&D and factories that produce its complex robotic devices that change people's lives.
Book value of all companies included in the broad market index - GURU.Markets
ReWalk Robotics' assets include development centers and manufacturing facilities for the creation of exoskeletons that enable people with lower-limb paralysis to walk again. The book value reflects the company's technological and industrial potential, creating revolutionary rehabilitation devices. The chart shows its weight.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - ReWalk Robotics Ltd.
ReWalk Robotics creates exoskeletons that help people walk. Its market value is determined by its revolutionary technology, patents, and the hope it offers patients. It's a premium on innovations that can radically change lives, not on the cost of the devices produced.
Market to book capitalization ratio in a market segment - Specialized medical equipment
ReWalk Robotics develops exoskeletons that help people with lower-limb paralysis walk again. This is a breakthrough technology. The chart shows how the market highly values ββits innovation and social impact, placing a significant premium on its tangible assets, betting on the future of rehabilitation.
Market to book capitalization ratio for the market as a whole
ReWalk Robotics creates exoskeletons that restore the ability to walk to people. It's a unique combination of sophisticated engineering and medical technology. This chart shows how the market views the innovation and raises the question: do investors view ReWalk as a technological visionary or a niche medical equipment manufacturer?
Debts of the company, segment and market as a whole
LFWD - Company debts ReWalk Robotics Ltd.
ReWalk Robotics, a pioneer in the development of exoskeletons for people with lower limb paralysis, is using the capital to fund R&D, clinical trials to secure insurance coverage, and expand sales. This timeline reflects the long and capital-intensive process of creating and bringing a revolutionary, yet niche, medical technology to market.
Market segment debts - Specialized medical equipment
ReWalk Robotics is a pioneer in the development of exoskeletons that enable people with spinal cord injuries to walk again. Commercializing such complex medical devices is a long and expensive process. This chart shows how the company uses capital for R&D, obtaining regulatory approvals, and convincing insurance companies to cover the costs of this breakthrough technology.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio ReWalk Robotics Ltd.
ReWalk Robotics produces exoskeletons that help people with spinal cord injuries walk again. The development, production, and commercialization of such complex medical equipment require significant investment. This chart shows how the company uses debt to fund its innovations and advancement in the rehabilitation technology market.
Market segment debt to market segment book capitalization - Specialized medical equipment
ReWalk Robotics develops exoskeletons that help people with spinal cord injuries walk again. This revolutionary technology is challenging to commercialize. This chart shows how the company is funding its R&D and market entry. It compares its debt load to the market capitalization of the entire medical device sector.
Debt to book value of all companies in the market
ReWalk Robotics develops exoskeletons that enable people with spinal cord injuries to walk again. This is a revolutionary, yet niche and capital-intensive technology. How heavily does the company rely on debt for R&D and bringing its product to market? This chart of total debt in the market helps assess the riskiness of its financial model.
P/E of the company, segment and market as a whole
P/E - ReWalk Robotics Ltd.
ReWalk Robotics (now Lifeward) develops and manufactures exoskeletons that enable people with spinal cord injuries to walk again. This chart shows how investors value the company in the rehabilitation robotics market. This valuation depends on expanding insurance coverage and the adoption of its technology in clinics.
P/E of the market segment - Specialized medical equipment
ReWalk Robotics develops and manufactures exoskeletons that enable people with spinal cord injuries to walk again. The company is a pioneer in wearable robotic rehabilitation devices. This chart illustrates the average valuation in the specialized medical equipment sector, which values ββtechnologies that fundamentally change patients' lives.
P/E of the market as a whole
ReWalk Robotics Ltd. develops and manufactures wearable robotic exoskeletons that help people with spinal cord injuries walk again. This chart reflects the overall sentiment in the medical technology sector. It helps us understand whether LFWD's high valuation is a result of faith in its revolutionary technology or a reflection of general industry optimism.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company ReWalk Robotics Ltd.
ReWalk Robotics develops exoskeletons that enable people with spinal cord injuries to walk again. The company's future depends on widespread adoption of this technology and securing insurance coverage. This chart reflects investors' confidence in exoskeletons becoming the standard for rehabilitation and in ReWalk's ability to establish a leading position in this market.
Future (projected) P/E of the market segment - Specialized medical equipment
ReWalk Robotics develops exoskeletons that help people with spinal cord injuries walk again. This is a revolutionary technology with enormous social impact. This section shows the sector's future profit expectations, allowing us to assess whether investors believe in the widespread adoption and commercial success of these complex medical devices.
Future (projected) P/E of the market as a whole
ReWalk Robotics develops exoskeletons that enable people with spinal cord injuries to walk again. This cutting-edge technology at the intersection of medicine and robotics. This overall market sentiment chart is an indicator of investor willingness to invest in breakthrough, yet capital-intensive, technologies that could radically change quality of life.
Profit of the company, segment and market as a whole
Company profit ReWalk Robotics Ltd.
ReWalk Robotics Ltd. develops and manufactures exoskeletons that enable people with spinal cord injuries to walk again. The company's profits depend on insurance coverage and the implementation of this revolutionary technology in rehabilitation centers. This chart shows the financial trajectory of the company, whose mission is to change the lives of people with limited mobility.
Profit of companies in the market segment - Specialized medical equipment
ReWalk Robotics Ltd. develops exoskeletons that enable people with spinal cord injuries to walk again. This revolutionary technology is life-changing. This chart reflects the overall profitability of the specialized medical equipment sector, where breakthrough innovations can create entirely new markets but require significant investment in R&D and clinical trials.
Overall market profit
ReWalk Robotics Ltd. develops exoskeletons that enable people with spinal cord injuries to walk again. Demand for this revolutionary technology is driven by medical needs and healthcare system capacity, not by economic conditions. The dynamics in this graph have little bearing on the company's commitment to restoring mobility to its patients.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company ReWalk Robotics Ltd.
ReWalk Robotics develops and manufactures exoskeletons that enable people with spinal cord injuries to walk again. The company's future profitability depends on regulatory approvals, insurance reimbursement, and the adoption of the technology in rehabilitation centers. This chart reflects analysts' expectations for the future of this breakthrough technology.
Future (predicted) profit of companies in the market segment - Specialized medical equipment
ReWalk Robotics is a pioneer in the development of exoskeletons that enable people with spinal cord injuries to walk again. The company strives to make this technology accessible for rehabilitation and everyday use. This graph shows revenue expectations for the specialized medical equipment sector, helping to assess the potential of ReWalk's revolutionary technology.
Future (predicted) profit of the market as a whole
ReWalk Robotics Ltd. develops exoskeletons that help people with mobility impairments regain their mobility. Demand for such expensive devices depends on insurance coverage and the financial state of the healthcare system. This economic outlook indirectly impacts ReWalk through its impact on healthcare budgets.
P/S of the company, segment and market as a whole
P/S - ReWalk Robotics Ltd.
ReWalk Robotics creates exoskeletons that help people with limited mobility walk again. Revenue growth for a company like this signifies more than just business success; it truly changes lives. This chart shows how investors value this revolutionary technology. The multiple reflects their belief in the widespread adoption of their products in medical practice.
P/S market segment - Specialized medical equipment
ReWalk Robotics develops and commercializes exoskeletons that enable people with spinal cord injuries to walk again. The company's technology is transforming patients' lives, restoring their mobility and independence. This chart shows the average revenue estimate for the sector, helping to understand how the market views this breakthrough and socially significant medical technology.
P/S of the market as a whole
ReWalk Robotics develops and manufactures exoskeletons that enable people with spinal cord injuries to walk again. The company is a pioneer in rehabilitation robotics. This chart helps illustrate the enormous premium investors are willing to pay for breakthrough medical technologies that can change lives, even with modest current revenue.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company ReWalk Robotics Ltd.
ReWalk Robotics develops and manufactures exoskeletons that enable people with spinal cord injuries to walk again. For a company with such breakthrough technology, valuation based on future revenue is key. It reflects investors' confidence in the wider adoption of this technology in rehabilitation practices and the potential for insurance reimbursement, paving the way for sales growth.
Future (projected) P/S of the market segment - Specialized medical equipment
ReWalk Robotics develops and manufactures exoskeletons that enable people with spinal cord injuries to walk again. This chart compares the company's estimated future revenue with other medical equipment manufacturers. It reflects investor expectations regarding the adoption of this revolutionary technology in rehabilitation and its accessibility to patients.
Future (projected) P/S of the market as a whole
ReWalk Robotics develops exoskeletons that enable people with spinal cord injuries to walk again. The company's growth depends on the adoption of this technology in rehabilitation centers and securing insurance coverage. This graph of investor expectations reflects their belief that breakthrough medical technologies can radically change people's quality of life.
Sales of the company, segment and market as a whole
Company sales ReWalk Robotics Ltd.
This metric for ReWalk Robotics reflects revenue from sales of exoskeletons that help people with spinal cord injuries walk again. Revenue is directly dependent on the number of systems sold to rehabilitation centers and individuals. The growth in the graph demonstrates the adoption of this revolutionary technology in medical practice and expanded patient access.
Sales of companies in the market segment - Specialized medical equipment
ReWalk Robotics develops and manufactures exoskeletons that enable people with spinal cord injuries to walk again. The company's sales breakdown shows how much revenue comes from personal devices and how much from rehabilitation centers. This reflects its dual focus on individual users and healthcare facilities.
Overall market sales
ReWalk Robotics Ltd. develops exoskeletons that help people with mobility impairments regain their mobility. The company operates at the intersection of medicine and robotics. Its growth depends on the introduction of innovations into rehabilitation systems. This overall economic activity impacts healthcare budgets, but technological advancement is ReWalk's primary driver.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company ReWalk Robotics Ltd.
ReWalk Robotics develops and commercializes exoskeletons that enable people with spinal cord injuries to walk again. The company's growth depends on expanding insurance coverage for these devices and their adoption in rehabilitation centers. This chart shows analyst sales forecasts, reflecting their views on the future of the rehabilitation robotics market.
Future (projected) sales of companies in the market segment - Specialized medical equipment
ReWalk Robotics Ltd. creates exoskeletons that help people with mobility impairments walk again. This chart illustrates the forecast for the medical rehabilitation equipment market. Is demand for robotic solutions growing thanks to technological advances? This demonstrates the potential of the entire advanced industry.
Future (projected) sales of the market as a whole
ReWalk Robotics develops exoskeletons that help people with musculoskeletal disorders regain their mobility. Demand for this expensive medical equipment depends on insurance coverage and rehabilitation center budgets. While the overall economic activity curve influences these factors, progress in collecting insurance reimbursements is more important for ReWalk.
Marginality of the company, segment and market as a whole
Company marginality ReWalk Robotics Ltd.
ReWalk Robotics develops and manufactures exoskeletons that enable people with spinal cord injuries to walk again. This graph shows the company's trajectory as it creates this revolutionary medical technology. Profitability depends on insurance reimbursement for the expensive devices and their widespread use in rehabilitation centers worldwide.
Market segment marginality - Specialized medical equipment
ReWalk Robotics Ltd. develops and manufactures exoskeletons that enable people with spinal cord injuries to walk again. The company's profitability depends on production costs, regulatory approval, and, crucially, insurance reimbursement. This metric reflects the challenging path to profitability for this pioneer in robotic rehabilitation.
Market marginality as a whole
ReWalk Robotics, which creates exoskeletons for people with mobility impairments, operates at the intersection of medicine and high technology. This gross profit chart reflects the state of the economy, which affects the ability of healthcare systems and insurance companies to pay for expensive rehabilitation equipment, which is key to the company's growth.
Employees in the company, segment and market as a whole
Number of employees in the company ReWalk Robotics Ltd.
ReWalk Robotics develops exoskeletons that help people with spinal cord injuries walk again. Its team of engineers and clinicians is the core of innovation. This chart shows how the company is investing in research and commercialization. The company's growth is driven by the development of new generations of devices and the expansion of its network of partner rehabilitation centers.
Share of the company's employees ReWalk Robotics Ltd. within the market segment - Specialized medical equipment
ReWalk Robotics is a pioneer in the development of exoskeletons that enable people with spinal cord injuries to walk again. Creating such complex mechatronic systems requires a team of top robotics engineers and clinicians. This graph shows the company's labor market share, reflecting its technological leadership and talent pool in the niche field of rehabilitation technology.
Number of employees in the market segment - Specialized medical equipment
ReWalk Robotics develops and manufactures exoskeletons that enable people with spinal cord injuries to walk again. This chart shows employment in the specialized medical equipment sector. ReWalk's technology is at the forefront of rehabilitation robotics, and growth in this niche reflects breakthroughs that are changing patients' lives.
Number of employees in the market as a whole
ReWalk Robotics develops exoskeletons that help people with mobility impairments walk again. This revolutionary technology, and the company's growth depends on its implementation in medical practice. This graph shows overall employment, and ReWalk illustrates how breakthrough innovations in medicine are creating entirely new professions and jobs at the intersection of robotics and healthcare.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company ReWalk Robotics Ltd. (LFWD)
ReWalk Robotics creates exoskeletons for people with mobility impairments. They operate in the high-tech and specialized medical equipment space. This chart reflects how the market values ββtheir unique developments. It shows a high market value per employee, typical for companies dominated by R&D and complex engineering.
Market capitalization per employee (in thousands of dollars) in the market segment - Specialized medical equipment
ReWalk Robotics (LFWD) creates exoskeletons that help people with musculoskeletal disorders regain their mobility. In the medical technology industry, this characteristic reflects the uniqueness of a product. A high employee rating can indicate that the company is a leader in its niche and its technology is unique, creating a high barrier to entry.
Market capitalization per employee (in thousands of dollars) for the overall market
ReWalk Robotics creates exoskeletons that help people with lower-limb paralysis regain their walking ability. In the field of medical robotics, value is determined by the uniqueness of the technology and patents. This chart shows how the market values ββthe revolutionary potential of a product that can change people's lives, which drives the high cost per engineer.
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company ReWalk Robotics Ltd. (LFWD)
ReWalk Robotics is a pioneer in the development of exoskeletons for the rehabilitation of people with spinal cord injuries. It's a knowledge-intensive business. This chart shows how commercially successful the company is. It reflects how much profit (or loss) the team of engineers and doctors generates from the sale of each complex and expensive robotic suit.
Profit per employee (in thousands of dollars) in the market segment - Specialized medical equipment
ReWalk Robotics Ltd. develops exoskeletons for people with limited mobility. In the production of complex medical equipment, efficiency depends on the balance between R&D and production costs. This graph shows how productive the team is in generating revenue, a key indicator of the commercial success of their unique technology compared to other manufacturers.
Profit per employee (in thousands of dollars) for the market as a whole
ReWalk Robotics (Lifeward) is a pioneer in medical exoskeletons that help people with spinal injuries walk again. This represents the intersection of robotics and medicine. This business requires elite engineers for R&D and skilled technicians for assembly. This graph shows how the efficiency of such high-tech medical technology compares to the average profit per worker in the economy.
Sales to employees of the company, segment and market as a whole
Sales per company employee ReWalk Robotics Ltd. (LFWD)
ReWalk Robotics creates exoskeletons that help people with limited mobility walk again. This graph demonstrates the commercial success of their unique technology. The growth in revenue per employee reflects the high value and social impact of their products, as well as the ability of a small team of engineers to change people's lives.
Sales per employee in the market segment - Specialized medical equipment
ReWalk Robotics develops exoskeletons that enable people with spinal cord injuries to walk again, as well as post-stroke rehabilitation systems. It's cutting-edge medical technology. This graph shows the average output in the sector. For LFWD, this is an indicator of how productive their R&D and specialized sales teams are in promoting these expensive and complex devices.
Sales per employee for the market as a whole
ReWalk Robotics creates exoskeletons that literally allow people with spinal cord injuries to walk again. This is the pinnacle of medical engineering. This metric reflects the effectiveness of their science-intensive model: how successfully their R&D team and specialized manufacturing facility create and market these complex, expensive devices.
Short shares by company, segment and market as a whole
Shares shorted by company ReWalk Robotics Ltd. (LFWD)
ReWalk Robotics (LFWD) develops exoskeletons that help people with spinal cord injuries walk again. It's an inspiring but commercially challenging technology. This chart shows the number of bearish bets. The shorts may be due to concerns that the high cost of exoskeletons and the difficulty of obtaining insurance coverage will limit their market potential.
Shares shorted by market segment - Specialized medical equipment
ReWalk Robotics (LFWD) is a pioneer in robotic exoskeletons that help people with spinal cord injuries walk again. This chart shows the overall shortfall in the specialized medical equipment sector. It highlights investor concerns about the slow adoption of these technologies in clinics (due to their high price).
Shares shorted by the overall market
ReWalk (LFWD) produces exoskeletons. This is an expensive, innovative technology. When this fear indicator rises, investors anticipate a recession. They fear that hospitals and patients, faced with budget cuts, will immediately freeze purchases of expensive, "unproven" equipment.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator ReWalk Robotics Ltd. (LFWD)
ReWalk Robotics (LFWD) develops exoskeletons that enable people with spinal cord injuries to walk again. This revolutionary technology has a high social impact. This indicator measures trend strength. It shows when stocks are "overheated" (above 70) due to regulatory news or "oversold" (below 30) due to slow commercial adoption.
RSI 14 Market Segment - Specialized medical equipment
ReWalk Robotics (LFWD) is a pioneer in medical exoskeletons. Its robotic suits enable people with spinal cord injuries to walk again. The company also develops rehabilitation solutions. This chart tracks the collective sentiment in the specialized medical equipment sector, helping to assess how investors view this unique niche in rehabilitation robotics.
RSI 14 for the overall market
ReWalk Robotics (LFWD), an exoskeleton developer, sees both hospital budgets and risk appetite in this graph. In a euphoric mood, investors are ready to finance the "future of medicine," and hospitals are ready to buy expensive innovations. In a panic, investors flee unprofitable R&D projects, and hospitals freeze capital expenditures.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast LFWD (ReWalk Robotics Ltd.)
ReWalk Robotics is a pioneer in the production of exoskeletons that enable people with spinal cord injuries to walk again. This chart shows the average analyst forecast. Their targets are based on sales of rehabilitation systems and, crucially, on progress in obtaining insurance coverage (Medicare) for personal use.
The difference between the consensus estimate and the actual stock price LFWD (ReWalk Robotics Ltd.)
ReWalk Robotics (LFWD) is a pioneer in exoskeletons that enable paraplegics to stand and walk again. This chart measures the gap between the current price and the consensus target price. It shows whether experts believe insurers will begin to cover this expensive but life-changing technology on a large scale.
Analyst consensus forecast for stock prices by market segment - Specialized medical equipment
ReWalk Robotics (LFWD) is a pioneer in the field of exoskeletons. The company produces robotic suits that enable people with spinal cord injuries to walk again. This chart shows general expectations for the specialized medical equipment sector. It reflects whether experts believe in the commercialization of wearable robotics.
Analysts' consensus forecast for the overall market share price
ReWalk Robotics (LFWD) is a pioneer in "walking robots." They produce exoskeletons that enable people with spinal cord injuries to stand up and walk. This is a life-changing technology. This chart shows the overall risk appetite. It reflects the market's willingness to fund companies whose breakthrough medical technologies are changing patients' lives.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index ReWalk Robotics Ltd.
ReWalk Robotics is a pioneer in exoskeletons. They were the first to receive FDA approval for a personal exoskeleton that allows people with spinal cord injuries to stand and walk at home. This chart summarizes their implementation history. It reflects their (very slow) path to insurance reimbursement and their struggle to reach the mass market.
AKIMA Market Segment Index - Specialized medical equipment
ReWalk Robotics (LFWD) is a pioneer in robotic exoskeletons. Their systems (ReWalk, ReStore) help patients with spinal cord injuries walk again and recover from strokes. This chart shows the average index for the segment, helping investors assess how commercially successful this life-changing technology is compared to the average.
The AKIM Index for the overall market
ReWalk Robotics (Lifeward) is a manufacturer of exoskeletons for people with spinal cord injuries and rehabilitation devices. This chart, which reflects the market average, is just a backdrop. It helps assess how LFWD, a pioneer in walking robotics, compares to overall macroeconomic trends.